Loading…
Potential contribution of beneficial microbes to face the COVID-19 pandemic
[Display omitted] •Microbiota in dysbiosis can facilitate infections.•Angiotensin-converting enzyme 2 allows coronavirus invade pulmonary and gut cells.•Oral infection is a possible route for SARS-CoV-2.•Consumption of beneficial microbes may help to better face an infection. The year 2020 will be r...
Saved in:
Published in: | Food research international 2020-10, Vol.136, p.109577-109577, Article 109577 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•Microbiota in dysbiosis can facilitate infections.•Angiotensin-converting enzyme 2 allows coronavirus invade pulmonary and gut cells.•Oral infection is a possible route for SARS-CoV-2.•Consumption of beneficial microbes may help to better face an infection.
The year 2020 will be remembered by a never before seen, at least by our generation, global pandemic of COVID-19. While a desperate search for effective vaccines or drug therapies is on the run, nutritional strategies to promote immunity against SARS-CoV-2, are being discussed. Certain fermented foods and probiotics may deliver viable microbes with the potential to promote gut immunity. Prebiotics, on their side, may enhance gut immunity by selectively stimulating certain resident microbes in the gut. Different levels of evidence support the use of fermented foods, probiotics and prebiotics to promote gut and lungs immunity. Without being a promise of efficacy against COVID-19, incorporating them into the diet may help to low down gut inflammation and to enhance mucosal immunity, to possibly better face the infection by contributing to diminishing the severity or the duration of infection episodes. |
---|---|
ISSN: | 0963-9969 1873-7145 |
DOI: | 10.1016/j.foodres.2020.109577 |